NCT02483169 - PreventIon of IMT Progression in iSchemic Stroke Patients With High Risk of Cerebral HemOrrhage-IMT Study | Biotech Hunter

Enrollment

800

Participants

Timeline

Start Date

June 30, 2009

Primary Completion Date

September 30, 2016

Study Completion Date

December 31, 2016

Conditions

Brain IschemiaIntracranial Hemorrhages

Interventions

DRUG

cilostazol

Cilostazol 100mg bid

DRUG

Probucol

Probucol 250mg bid

DRUG

Aspirin

Aspirin 100mg qd

DRUG

placebo of cilostazol

same shape and size of active cilostazol

DRUG

Placebo of aspirin

same size and shape of active aspirin 100mg

DEVICE

Intima-medial thickness

ultrasound measured IMT of both common carotid arteries